Ephedrine is thought to exert behavioural effects primarily through actions on the central nervous system. However, the neuromechanism underlying the effects of ephedrine addiction still remains unclear. Our study aimed to establish chronic ephedrine addiction models in rhesus monkeys and to investigate the neuromechanism of chronic ephedrine addiction using the behavioural methods combined with resting-state blood oxygenation level dependent-functional magnetic resonance imaging (BOLD-fMRI). Monkeys in the ephedrine addiction group (n = 6) received intramuscular injections of ephedrine using a dose escalation method, with a chronic model established in 8 weeks, while in the control group (n = 4), monkeys received a pure 0.9% saline injection. The weight and behaviors of the monkeys were observed throughout the treatment. All monkeys underwent the brain MR scans for two times (before treatment and after treatment had been discontinued). After molding, the weight of the ephedrine group was significantly reduced, while the weight of the control group increased significantly. Compared with the control group, the ephedrine addicted monkeys showed more abnormal behaviors related to addiction. In fMRI study, the ephedrine addicted monkeys showed more increased brain activation than that of the control group, mainly including the prefrontal cortex(PFC) and anterior cingulate cortex (ACC), the left ventral tegmental area(VTA), right insula, right amygdala, hippocampus, left thalamus, and left cerebellum.We hypothesize that the principal neuromechanism underlying chronic ephedrine addiction involves multiple abnormal brain neuron circuits, mainly in the PFC and the limbic system, and is closely related to addictive behaviors.
Introduction
Ephedrine, which is a new generation of drugs, is gradually replacing opium, heroin, marijuana, cocaine and other illicit drugs, and is becoming one of the most widely abused and harmful drugs in the world [1] [2] [3] . Ephedrine is also the main synthetic material of amphetamine drugs, which account for the majority of chronic drug addictions. It has been reported that chronic administration of amphetamines directly damages nerve tissue and impairs nerve function [4] [5] [6] . The researches also have shown that ephedrine in animal models could produce amphetamine-like effects [7] [8] [9] . For example, acute ephedrine treatment can cause hyperactivity in rats, and repeated infusion of ephedrine can cause locomotor sensitization in rats [1] . Most previous studies of drug addiction have used large drug doses with animal models of acute poisoning. This type of research produces simple, obvious effects, and consistent results, and has other characteristics that are favored by many researchers. For example, the dose usually administered to rats in those studies is 10 mg/kg, 4-5 times per day, at 2-hour intervals, or a single administration of 40 mg/kg [10] [11] [12] . These models are substantially different from human drug addiction, and some scholars have pointed out that short-term acute addiction treatment is likely to cause a dangerous elevation of body temperature and may even cause death. Such heat injury may be related to the body's toxicity [13] . However, the neuromechanism underlying the effects of https://doi.org/10.1016/j.bbr.2018.07.024 Received 4 May 2018; Received in revised form 3 July 2018; Accepted 27 July 2018 ephedrine addiction still remains unclear. Therefore, it is very important to study the mechanisms of neural dysfunction associated with chronic ephedrine addiction.
Functional magnetic resonance imaging (fMRI) is an intuitive, noninvasive imaging tool that dynamically reflects physiological activity throughout the brain [14, 15] . fMRI has been utilized extensively to examine the neuromechanisms of drug addiction specificity. Previous fMRI studies have found that drug addicts exhibit activation of the brain regions for reward, memory, and emotion processing [16, 17] . However, these studies have investigated event-related states, and there are few studies that have used resting-state fMRI (rs-fMRI) to investigate drug addiction.
Conventional animal studies of drug addiction mainly use surrogate animals like rats, but these animals belong to a different order of mammals than humans do, and their physical structure is significantly different from humans. Moreover, their small body and brain size make the test data less reliable. Monkeys and other nonhuman primates have many similarities with humans in terms of their organizational structure, physiology, and biochemistry. The researches on non-human primates should provide a better understanding of human physiology and diseases. Howell et. al., [18] used rhesus monkeys as experimental subjects in a study of cocaine administration, but it only investigated acute effects. No research on chronic ephedrine addiction using rhesus monkeys has been reported.
In this study, first at all, we used rhesus monkeys to establish chronic ephedrine addiction models. Secondly, we investigated the neuromechanism of chronic ephedrine addiction using behavioural and rs-fMRI methods. We hypothesized that multiple abnormal brain neuron circuits were the main neuromechanisms of chronic ephedrine addiction, and that were closely related to addictive behaviors. Thus, this study can provide a scientific basis for drug addiction withdrawal therapy.
Materials and methods

Ethical statement
Rhesus monkeys care and procedures were in accordance with the guidelines on the treatment of experimental animals (the National Science Foundation (2006), Publication No. 398, 2006-10-08). The current experiments were approved by the Medical Animal Care and Welfare Committee of Shantou University Medical College in Shantou City, Guangdong Province, China (No. SUMC2011-006).
Animals and materials
Ten healthy adult male rhesus monkeys (Macaca mulatta) were purchased from Guangzhou Xusheng Biological Technology Co., Ltd. They were randomly divided into two groups: the ephedrine addiction group (n = 6; mean age = 4.80 ± 0.26 years; mean weight = 8.04 ± 0.15 kg) and the saline control group (n = 4; mean age = 4.87 ± 0.35 years; mean weight = 8.07 ± 0.13 kg). There was no significant difference between the age, weight and behavior scores of the two groups before treatment (P > 0.05). Demographic data of the two groups' rhesus monkeys before treatment was presented in Table 1 . All monkeys were in good nutritional and normal mental states, with no history of nervous system problems, or history of drug use. The animals were well-fed by specialized laboratory animal keepers, lived in individual stainless-steel cages (60 cm × 60 cm×80 cm) in the same battery-type animal room, and had daily access to food (Harlan Teklad monkey chow; fresh fruit and vegetables) and unlimited access to water. The animal house was a bright and spacious room with the 12 h light-dark cycle, and was equipped with full insulation and ventilation equipment so that the temperature and humidity were controlled to ensure the most appropriate condition for monkeys: the temperature was 24°C, and the relative humidity was 40% to 70%. Music was usually played at a fixed time for their everyday entertainment.
Ephedrine was purchased from the National Institutes for Food and Drug Control (CHN) (No.171241-2011007), specifications: 20 mg/ branch. In our experiment, the ephedrine was dissolved in 0.9% saline. The procedures were in line with the Drugs and Psychotropic Substances Management System of the First Affiliated Hospital of Shantou University Medical College and the Guangdong Key Laboratory of Medical Molecular Imaging.
Chronic ephedrine addiction model
We established chronic ephedrine addiction models in rhesus monkeys using a dose escalation method [19, 20] . Monkeys in the ephedrine addiction group received intramuscular injections of ephedrine in the buttocks beginning with a low dose of 0.4 mg/kg/d, one time a day(at 10:00 a.m.), which was suspended for one day after three continuous days of injections. The dose was increased twice a week for the first three weeks, and then a dose of 3.2 mg/kg/d was maintained from 4th week until the end of the 8th week. Thus, we established chronic ephedrine addiction models in rhesus monkeys. The control group received a pure 0.9% saline injection, the dose and all the other procedures were the same as those for the ephedrine addiction group.
Behavioral observations
The changes in the weight and behaviors of the two groups were observed throughout the treatment, and one week before treatment and after treatment had been discontinued, a total of 10 weeks. The behaviors of the monkeys was observed and scored three times daily at 08:00 a.m., 14:00 p.m., and 20:00 p.m., daily observations were performed at least 2 h, the behavioural symptoms of each monkeys were recorded, and also the frequencies of each behavioural symptom (for if a symptom is repeated throughout the day, the symptom score should be reduced by 1 point), each behavioural symptom was a single score, and then all behaviors were combined, the total score is calculated according to the formula: S]A + B; S = Total score of each rhesus monkeys' symptom；A = The level differenc；B = The total score for all symptoms in a day (According to Table 2), and weekly averages of behavioural scores were calculated. The behaviors recordings including all the behavioural symptoms that were listed in Table 2 . The behaviors of all monkeys were observed in an observation room near the animal room equipped with special equipment. The behaviors were scored by three raters, unaware of the treatment, who tallied the frequency of occurrence of each behavior on a standard scoring sheet (differential grades + symptom grades) [21] , the behavioural criteria for drug addiction in nonhuman primates was list in Table 2 . In this study, it is worth emphasizing that some of the behaviors elicited by chronic ephedrine addiction (e.g. limb flicking, stereotyped behaviors, and sympathomimetic signs) are the same as those behaviors elicited by other drug addictions that have been described in rhesus monkeys by Ellinwood [22] . Limb flicking is a behavior in response to the presence of a foreign substance on the paw. The paw is then lifted and rapidly snapped or flicked outward from the body. Head shakes are responses to remove foreign substances. Aborted grooming is scored when a monkeys orients to the body surface as if to groom, but does not display the consummator grooming responses (bite, lick, or scratch) or displays the responses in midair. Staring is scored when a monkey fixates the eyes in one direction for 5 s. Rubbing the head with the forepaw, licking, and scratching are all subsumed under grooming. Investigatory responses refer to pawing or sniffing at objects or in corners, chasing the tail, or batting at pieces of food, feces, etc. Hallucinatory-like responses are scored when a monkey looks around at the floor, ceiling, or walls of the cage, and appears to be tracking objects visually. In addition, stereotyped behaviors and sympathomimetic signs were scored daily, such as a fixed gross body position accompanied by rhythmic bobbing and/or weaving of the head and upper body and a high frequency of the eye movements. The most prominent sympathomimetic signs produced by chronic ephedrine addiction are mydriasis, salivation, panting, and vomiting. The intensity of the chronic ephedrinedependent symptoms was rated on four levels: mild, moderate, severe, and very severe ( Table 2 ). The average weekly weight of all monkeys was also calculated.
MR Imaging data acquisition
MR imaging data were acquired by using a Siemens Magnetom Trio Tim 3.0 T MR scanner in the Department of Radiology of the First Affiliated Hospital of Shantou University Medical College. We had a professional animal experimenter monitoring the monkeys during the procedure. All monkeys underwent brain MR scans for two times (before treatment and after treatment had been discontinued). The monkeys were anaesthetized with 4% isoflurane gas anaesthesia and placed into a replica of the restraint unit used for fMRI studies. Cod liver oil was affixed to the left ear as a mark, and the head was placed in the head coil with a respirator and ECG monitoring of the anaesthesia state, the life indicators of the monkeys were closely observed and recorded during the whole scanning process to ensure safety.
First, axial anatomic images were acquired in each monkey with a T1 anatomical imaging of conventional SE sequences, the following parameters were used: TR = 349 ms, TE = 3.95 ms, 42 slices, flip angle = 90°, field of view = 108 × 108 mm, matrix = 128 × 128, slice thickness = 1.8 mm, and intersection gap = 0 mm. Subsequently, a gradient-echo echo-planar (GRE-EPI) sequence sensitive to BOLD contrast material was used to acquire functional images with the following parameters: TR = 3100 ms, TE = 27 ms, flip angle = 90°, field of view = 108 × 108 mm, matrix = 64 × 64, slice thickness = 1.8 mm, and intersection gap = 0 mm. Each brain volume consisted of 42 axial slices and each functional dataset contained 164 image volumes. Each fMRI scan lasted 512 s. Finally, fast low-angle radio frequency pulse sequence was used to acquire 3D data of the whole brain with the following parameters: TR = 1900 ms, TE = 2.57 ms, flip angle = 30°, field of view = 108 × 108 mm, matrix = 128 × 128, slice thickness = 0.9 mm, and intersection gap = 0 mm, 88 slices.The sections were obtained approximately along the anterior commissure-posterior commissure line.
fMRI resting-state analysis
The original fMRI data were converted using MRI Convert software (http://lcni.uoregon.edu/). Image processing and analyses were performed with AFNI(Analysis of Functional NeuroImages, a set of C programs for processing, analyzing and displaying fMRI data. http:// afni.nimh.nih.gov/afni/), including data preprocessing, statistical analysis and result display. The following preprocessing steps were applied to all images. The beginning ten volumes of each dataset were discarded for occurrence of a steady state, the remaining 154 volumes were motion corrected all functional data sets were processed to remove any linear drift, to correct for motion, be normalized to the stereotaxic coordinates of the Talairach and Tournoux atlas for the rhesus monkey [23] , and spatially smoothed with a Gaussian filter (FWHM = 6 mm). Any scan in which the head motion was larger than 2 mm or rotation larger than 2°was excluded from further analysis. No scans met criteria for excessive motion; all data were used. After this analysis, dual-regression analysis was performed, the aim of which was to create personalized maps of each network for every monkey. The first step of the dual-regression is creating the average time course within each network for each subject, which is done using a linear model fit of each group-based network map onto each monkey's fMRI dataset (spatial regression). After this, the personalized time course is regressed back onto that monkey's fMRI dataset to create personal spatial maps for each network after variance normalization using another linear model fit (temporal regression). A single four-dimensional file of all components was created for each participant. Because of the normalization of the variance of the time series used in the final regression, these spatial maps reflect both amplitude of spontaneous fluctuation in a network and its coherence (correlated BOLD signals) across space. The individual values in these maps, therefore, represent connectivity in a more sophisticated way than just a coherence measure (which implies independence of amplitude) (False Discovery Rate (FDR) correction, P < 0.05, cluster size ≥ 10 voxels). Group differences were tested using nonparametric permutation testing, corrected for age, body weight, and behavioural symptoms. Data were corrected for multiple comparison using threshold-free cluster enhancement, which allows the identification of clusters of significant voxels without having to define them in a binary way, as well as family-wise error, using a final FDR correction, P < 0.05, cluster size ≥ 10 voxels. We investigated three different contrasts: (1) The monkeys that were injected with saline compared with their brain activation before the experiment, (2) The brain activation of monkeys with chronic ephedrine addiction compared with that before the experiment, (3) The brain activation of rhesus monkeys with chronic ephedrine addiction compared with the control group. Each contrast was tested in increases, resulting in three final contrasts. The group ANOVA was performed to compare the different activation of the two groups, and these activation maps were used to locate the regions of interest (ROIs). 
Statistical analysis
All datas of the ten monkeys were quantified forstatisticalanalysis. The Demographic data, the behavioural scores and weight changes of the two groups' rhesus monkeys, were compared using two independent-samples t-tests and repeated-measures analysis of variance (ANOVA). The statistical analyses were conducted using SPSS 20.0, and a corrected P value less than 0.05 was considered significant.
Results
Behavioral results
Before the experiment, the weight and behavioural scores of the two groups have no significant differences(P > 0.05). Thus, the two groups can be considered to be comparable.
Weight changes
A repeated-measures ANOVA indicated that the weight of the control group gradually increased, while the weight of the experimental group decreased significantly (F = 44.813, P < 0.001).
two independent-samples t-tests showed that the weight of the experimental group was significantly lower than the weight of the control group after modeling (P < 0.001), and the weight of the two groups monkeys was significantly different from the 5th week (P < 0.05) (Fig. 1). 
Behavioral scores
From the 4th week, the ephedrine addicted group monkeys began to exert more abnormal behaviors, and their behavioural scores were significantly higher than those of the control group (P < 0.01). After 8 weeks modeling, the chronic ephedrine addicted monkeys showed various degrees of withdrawal symptoms, mainly craving, malaise, and impulsivity. At the beginning of the experiment, the addicted monkeys showed persistent upright exploration, climbing, etc. After a time, these activities gradually declined and the addicted monkeys appeared tired and apathetic, but even a mild stimulus could cause obvious symptoms of irritability, such as piloerection and jumping attacks. According to the behavioural scoring standards, the behaviors of the ephedrine addicted monkeys were significantly different from the control group (F = 431.184, P < 0.001) (Fig. 2) .
fMRI results
Brain activation of the saline control group
The monkeys that were injected with saline showed no fMRI differences compared with their brain activation before the experiment. Their brain activity was mainly distributed in the superior frontal gyrus, middle frontal gyrus, right anterior cingulate cortex (ACC), right temporal gyrus, insula, cerebellum, the right thalamus, and the right precuneus (Fig. 3). 
Brain activation of the Ephedrine addiction group
The brain activation of monkeys with chronic ephedrine addiction mainly occurred in the bilateral frontal and parietal lobe, anterior cingulate cortex (ACC), insula, precuneus, cerebellum, the ventral tegmental area (VTA), the bilatera thalamus, the right hippocampus, and the right amygdala (Fig. 4) .
Comparison of the activated brain regions of the two groups
Compared with the control group, rhesus monkeys with chronic ephedrine addiction showed more increased brain activation, mainly in the prefrontal cortex(PFC) and the limbic system (especially the left side), including the bilateral superior frontal gyrus/middle frontal gyrus (SFG/MFG), orbit frontal cortex (OFC), anterior cingulate cortex (ACC), inferior parietal lobe (IPL), and precuneus (FDR correction, P < 0.01). The above-mentioned different brain activation map of the two groups were used to locate the regions of interest (ROIs). Other regions of brain activity were the right inferior frontal gyrus (IFG), the insula, the ventral tegmental area (VTA), the left temporal pole, the right amygdala and hippocampus, the left thalamus, and the left cerebellum (FDR correction, P < 0.05). (Table 3 , Fig. 5 ).
Discussion
Ephedrine has become one of the most widely abused and harmful drugs around the world, since it is often used as an adrenergic drug, which is very easy to get and misuse. Ephedrine is thought to exert behavioural effects primarily through damaged actions on the central nervous system. However, the neuromechanism underlying the effects of ephedrine addiction still remains unclear. Although many animal models have been established to study the dysfunctional neural mechanisms of drug addiction, they are mostly based on large doses or acute poisoning. There are no chronic models, which are needed to study human addiction, and few of the models use non-human Fig. 1 . Weight changes of monkeys in the Ephedrine addicted group and the Saline control group. Comparison between the ephedrine-addicted group and the saline control group using two independent-samples t-test, *: P < 0.05,**: P ≤ 0.001.
primates. This study aimed to create chronic ephedrine addiction models on rhesus monkeys, and to investigate the neuromechanism of chronic ephedrine addiction using behavioural and resting-state BOLDfMRI methods. Thus, the results of the study can provide a scientific basis for drug addiction withdrawal therapy.
The monkeys exhibited behaviors that were consistent with drug addiction. Our results showed that chronic ephedrine addicted rhesus monkeys exerted a significant reduction in food intake, followed by weight decline, which are similar to the human symptoms of decreased appetite and body weight loss (as well as other symptoms) due to the drug's inhibition of appetite. A study reported that drugs can act on the animal feeding center outside of the hypothalamus, resulting in reduced food intake [24] . In this study, the behavioural score of the ephedrine addiction group was significantly different from that of the control group from the 5th week, while the weight change was significantly different by the 4th week. We hypothesized that the weight reduction of the addicted monkeys might due to decreased food intake, but it may also be related to the increases of various addictive behaviors and physical exertion.
In our study, the chronic ephedrine addicted monkeys showed increasing stereotyped behaviors, which mainly consisted of active exploration, such as upright exploration and climbing behaviors. After a period of time they appeared to be tired and apathetic, but also exhibited agitation. In conclusion, the chronic ephedrine addicted monkeys showed withdrawal symptoms like craving, malaise, and impulsivity, which are similar to human drug addiction [25] . Compared with other studies of acutely addicted animals, their behaviors, such as twisting the head, piloerection, and spontaneous circling movements were substantially reduced [26] . These behaviors may be associated with ephedrine related sympathomimetic-adrenergic effects [27] . The sympathetic nerves of the monkeys were stimulated after the ephedrine injection, resulting in symptoms of sympathetic nervous excitement, because such excitement and increases of movements. It might also be related to the increased release of dopamine, for one of dopamine's roles is to regulate mood and behavior [7, 27] . After modeling, the chronic ephedrine addicted monkeys showed reduced activity, Fig. 2 . Behavioral scores of monkeys in the Ephedrine addicted group and the Saline control group. Comparison between the ephedrine-addicted group and the saline control group using two independent-samples t-test, *: P < 0.05,**: P ≤ 0.001. listlessness, and increased irritability. Their performance was different from the short-term acute addiction treatment animal models, and we hypothesized that it might represent the characteristic symptoms of chronic drug poisoning. Compared with the rs-fMRI results of the control group, the chronic ephedrine addicted monkeys showed more and larger voxel numbers of brain activation, mainly in the PFC and the limbic system. Studies have reported that drug addiction can consistently induce cravings in patients that are associated with activity in the frontal, orbital frontal cortex, anterior cingulate cortex, posterior cingulate cortex, midbrain tegmental area, ventral tegmental area, amygdala, hippocampus, cerebellum, and other brain regions [16, 28] . Ephedrine is similar in several respects to D-amphetamine and methamphetamine. Multiple doses of ephedrine can cause severe hyperthermia and neurodegeneration in the rat brain [29] . It was reported that chronic administration of ephedrine induced obvious neurodegeneration in mice prefrontal cortex [6, 30] , and that may be the result of excitotoxic mechanisms. This study found that the bilateral SFG/MFG, OFC, ACC, MPFC, and insula, ventral tegmental area (VTA), right amygdala and hippocampus, the left thalamus, pons, and the left cerebellum were significantly more activated in the chronic ephedrine addiction group than that of the control group. This showed that ephedrine can induce the activation of specific brain regions that are associated with craving, which is similar to the results of previous studies.
The PFC is the integration hub of information and is associated with working memory, preparedness planning and actions, as well as misconduct and attention to drug-related stimuli, and it plays an important role in cognitive processing [31, 32] . The neural activity of the prefrontal cortex substantially increased during the craving process, which may indicate that drug addicts give more attention to drugs, and through the participation of working memory, this may initiate and maintain the desired state. Zhang [5] found that chronic administration of Ma Huang induced obvious neurodegeneration in rat brains, with the prefrontal cortex showing the greatest effect. The ACC is primarily related to attention and motivation. A study by Wexler et al. [33] used task fMRI to assess cocaine-induced craving found the same results as our experiment; the authors speculated that the activation of the ACC might be specific to the emotional state of drug craving, and that the ACC had a unique role in drug-induced craving. The function of cerebellum is not limited to the traditionally recognized function of adjusting movements and balance; it has a role in the mediation of affective and cognitive processes that makes it a brain region of increased interest [34] . Drug-induced cerebellar activation, may be due to addiction to drugs that stimulate the mobilization of more attention and emotional processing [35] . The above studies indicated that chronic ephedrine addiction could activate a wide range of brain regions associated with craving, reward, learning and memory, and other neuronal activity, that formed an emotional processing loop involved in the formation and maintenance of desire. They included the nucleus accumbens and ventral pallidum loop that regulated reward processes, the orbital frontal cortex and cingulate cortex that regulated motivation and emotional reactions, the amygdala and hippocampus that underlie FDR correction, P < 0.05, Cluster size ≥ 10; Abbreviations: SFG = superior frontal gyrus; MFG = middle frontal gyrus; IFG = inferior frontal gyrus; OFC = orbit frontal cortex; ACC = anterior cingulate cortex; IPL = inferior parietal lobe; VTA = ventral tegmental area; L = left; R = right. learning and memory and support conditions, and the PFC and ACC were in charge of higher cognitive control and executive functions, as well as other neural circuits. In our preliminary study [3] , we showed that the significant changes in both the body weight and behaviors of rhesus macaques with chronic ephedrine addiction were closely related to the CREB expression in the hippocampus. These circuits independently accept direct and indirect projections, which play an important role in the regulation of craving [36] [37] [38] .
Conclusions
We successfully established chronic ephedrine addiction models on rhesus monkeys, the behaviors, body weight, and functional brain changes of the ephedrine addicted rhesus monkeys showed the characteristic signs of toxic injury. Our study demonstrated that the principal neuromechanism underlying chronic ephedrine addiction involves multiple abnormal brain neuron circuits, mainly in the prefrontal cortex and the limbic system. Thus it could provide a scientific neuroanatomical basis for drug addiction withdrawal therapy. Although the present study have outlined the principal neuromechanism of ephedrine addiction, more in-depth researches are needed to explore the precise functional brain changes, combined with pathology, cellular electrophysiology, and molecular biology techniques, in order to confirm them.
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